HONSIMBA Vial Filling Machine Speed Adaptation Solution: Solving the Efficiency-Quality Balance Problem for Pharmaceutical Enterprises

Many pharmaceutical companies have suffered losses due to speed issues: some pushed the filling speed too high, resulting in an expansion of filling quantity deviations, a sharp increase in product non-conformity rates, and significant increases in rework and scrap costs; some had long adjustment times when producing multiple specifications, causing serious waste of production capacity and also triggering customer complaints due to improper debugging; some had unstable equipment speeds, with excessive residual drug liquid, failing to pass GMP inspections and facing the risk of production suspension and rectification.

Blindly increasing speed led to inaccurate filling volume and liquid leakage and scrap; insufficient speed was unable to meet production orders; the adjustment for multiple specifications was cumbersome; unstable speed affected compliance, resulting in monthly losses of tens of thousands. The HONSIMBA vial filling machine adaptation solution precisely addresses these problems and achieves efficiency and quality win-win.

HONSIMBA precisely targets these issues: based on the characteristics of the drug liquid and the bottle type specifications, it adapts the optimal speed to avoid excessive speed increase losses; it is equipped with an intelligent adjustment system, allowing multiple specifications parameters to be preset, and the type change can be stabilized within 10 minutes with a significant reduction in adjustment time; it uses "servo motor + real-time feedback" control, with speed fluctuations reduced to ±10 bottles per hour, ensuring filling accuracy and automatically recording the speed curve to assist in compliance inspections.

In actual applications, after enterprises replaced their equipment, the filling volume qualification rate rose to over 99.8%, and the rework and scrap costs were significantly reduced; the efficiency of multiple specifications production was improved, and there was no need for outsourcing orders; the speed stability met the standards, and the production was successfully passed the regulatory inspections. For pharmaceutical companies, speed "adaptation is king", and the HONSIMBA solution makes speed a competitive advantage rather than a production burden.